Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Core Insights - Tango Therapeutics, Inc. is participating in the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025, with Adam Crystal, M.D., Ph.D., President of Research & Development, scheduled for a fireside chat [1] Company Overview - Tango Therapeutics is a clinical-stage biotechnology company focused on discovering novel drug targets and advancing precision medicine for cancer treatment [3] - The company utilizes the genetic principle of synthetic lethality to develop therapies targeting critical cancer-related targets [3] - More information about the company can be found on their website [3]